INmune Bio
INMB
INMB
42 hedge funds and large institutions have $25.3M invested in INmune Bio in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.04% more ownership
Funds ownership: 10.89% → 13.93% (+3%)
33% less capital invested
Capital invested by funds: $37.7M → $25.3M (-$12.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
42
Holding in Top 10
–
Calls
$574K
Puts
$425K
Top Buyers
| 1 | +$3.61M | |
| 2 | +$886K | |
| 3 | +$634K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$292K |
| 5 |
Millennium Management
New York
|
+$277K |
Top Sellers
| 1 | -$840K | |
| 2 | -$517K | |
| 3 | -$454K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$388K |
| 5 |
DCM
DG Capital Management
New York
|
-$388K |